First, the study focused exclusively on the LRRK2 G2019S mutation, and did not include other LRRK2 variants or familial PD-linked genes, nor did it systematically investigate sporadic PD beyond a single illustrative case. The gene discussed is LRRK2; the disease is Parkinson disease.